Home/Filings/4/0001384101-25-000002
4//SEC Filing

EASTHAM KARIN 4

Accession 0001384101-25-000002

CIK 0001384101other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:16 PM ET

Size

10.4 KB

Accession

0001384101-25-000002

Insider Transaction Report

Form 4
Period: 2025-01-02
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-02$5.28/sh+10,000$52,80028,497 total
  • Sale

    Common Stock

    2025-01-02$40.12/sh5,309$213,01023,188 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-01-0210,0000 total
    Exercise: $5.28Exp: 2026-06-20Common Stock (10,000 underlying)
  • Sale

    Common Stock

    2025-01-02$40.50/sh4,691$189,99618,497 total
Footnotes (4)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2024.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $39.46 to $40.36. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]Represents weighted average sales price. Sale prices for the transactions range from $40.37 to $40.78. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F4]The option is fully vested.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001231845

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:16 PM ET
Size
10.4 KB